Abstract :
Acute Myeloid leukemia (AML) is a cancer that develops quickly and spreads throughout the body in a short amount of time. In Iraq, there are 1674 new cases of leukemia registered in 2018. Interleukin-6 (IL-6) is a multifunctional interleukin which has an important action in AML.A 60 Iraqi individuals (30 newly diagnosed AML patients & 30 controls) have been chosen to estimate their IL-6 level in the serum. We found a significant decrease in IL-6 among AML-study groups than that of control (29.64367 ± 5.237342 vs. 34.76133 ± 3.472883) (t= -4.461, df: 58, P= 0.000) which is may be due to the high level of IL-37 which has a negative correlation with IL-6 in newly diagnosed AML patients. We recommend studying lager number of samples to get more understandings about the role of IL-6 role in newly diagnosed AML.
